Back to search

Mechanisms of acquired resistance to the orally active platinum-based anticancer drug bis-acetato-ammine-dichloro-cyclohexylamine platinum (i.v.) (JM216) in two human ovarian carcinoma cell lines.

Data up to Jan 2025

Published1994
Citations34
References0

Total Citations Per Year

Abstract

References (0)

No references found

Cited By (0)

No citing papers found in database

Mechanisms of acquired resistance to the orally active platinum-based anticancer drug… (1994) – PubMed | Metascience Observatory Explorer